109 related articles for article (PubMed ID: 7892031)
1. Computerized nuclear morphometry and survival in renal cell carcinoma: comparison with other prognostic indicators.
Delahunt B; Becker RL; Bethwaite PB; Ribas JL
Pathology; 1994 Oct; 26(4):353-8. PubMed ID: 7892031
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B
Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of nuclear morphometry in renal cell carcinoma.
Ozer E; Yörükoğlu K; Sagol O; Mungan U; Demirel D; Tüzel E; Kirkali Z
BJU Int; 2002 Jul; 90(1):20-5. PubMed ID: 12081763
[TBL] [Abstract][Full Text] [Related]
4. Value of morphometric nuclear image analysis using the Feulgen reaction in renal cell carcinoma.
Lee JS; Jung JJ; Lee MC; Park CS; Juhng SW; Oh BR; Moon JD
Anal Quant Cytol Histol; 2000 Feb; 22(1):31-6. PubMed ID: 10696458
[TBL] [Abstract][Full Text] [Related]
5. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K
Int J Cancer; 1993 Oct; 55(4):547-54. PubMed ID: 8406980
[TBL] [Abstract][Full Text] [Related]
6. Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation.
Artacho-Pérula E; Roldán-Villalobos R; Martínez-Cuevas JF; López-Rubio F
J Pathol; 1994 Jun; 173(2):105-14. PubMed ID: 8089804
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.
van der Poel HG; Mulders PF; Oosterhof GO; Schaafsma HE; Hendriks JC; Schalken JA; Debruyne FM
Cancer; 1993 Nov; 72(9):2667-74. PubMed ID: 8402488
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic prognostic indicators for renal cell carcinoma.
Delahunt B
Semin Diagn Pathol; 1998 Feb; 15(1):68-76. PubMed ID: 9503507
[TBL] [Abstract][Full Text] [Related]
9. Selective nuclear morphometry as a prognostic factor of survival in renal cell carcinoma.
Monge JM; Val-Bernal JF; Buelta L; García-Castrillo L; Asensio L
Histol Histopathol; 1999 Jan; 14(1):119-23. PubMed ID: 9987656
[TBL] [Abstract][Full Text] [Related]
10. A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma.
Nativ O; Sabo E; Bejar J; Halachmi S; Moskovitz B; Miselevich I
Br J Urol; 1996 Jul; 78(1):33-8. PubMed ID: 8795397
[TBL] [Abstract][Full Text] [Related]
11. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
Delahunt B; Bethwaite PB; Thornton A; Ribas JL
Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
[TBL] [Abstract][Full Text] [Related]
12. Nuclear morphometry of renal cell carcinomas.
Barth PJ; Siebel A; Gerharz E; Köhler HH
Gen Diagn Pathol; 1995 May; 141(1):29-33. PubMed ID: 8542504
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar organizer regions and prognosis in renal cell carcinoma.
Delahunt B; Ribas JL; Nacey JN; Bethwaite PB
J Pathol; 1991 Jan; 163(1):31-7. PubMed ID: 2002422
[TBL] [Abstract][Full Text] [Related]
14. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
[TBL] [Abstract][Full Text] [Related]
15. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the prognostic value of nuclear grade and silver-binding nucleolar organizer region in renal cell carcinomas.
Yang AH; Wang TY; Liu HC
J Pathol; 1992 Feb; 166(2):157-61. PubMed ID: 1560316
[TBL] [Abstract][Full Text] [Related]
17. Nuclear morphometry in male breast carcinoma: association with cell proliferative activity, oncogene expression, DNA content and prognosis.
Chiusa L; Margaria E; Pich A
Int J Cancer; 2000 Nov; 89(6):494-9. PubMed ID: 11102893
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural morphometry of nucleoli: potential usefulness for objective grading of clear cell renal cell carcinoma.
Lloreta-Trull J; Bielsa-Galí O; Domínguez-Solà D; Arumí-Uría M; Pavesi M; Gelabert A; Serrano-Figueras S
Ultrastruct Pathol; 2001; 25(2):105-10. PubMed ID: 11407523
[TBL] [Abstract][Full Text] [Related]
19. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
